On Sept. 25, The Pew Charitable Trusts’ drug spending research initiative submitted comments to Oregon’s Joint Task Interim Force on Fair Pricing of Prescription Drugs on how increasing the transparency of drug prices could help lower costs to the state.
Pew’s comments summarize a policy option that could help Oregon’s Medicaid program secure larger drug rebates and avoid overpaying for medications by requiring drug manufacturers to confidentially report discounts provided to pharmacy benefit managers and other negotiating entities.